AbbVie's Parkinson's disease drug meets main goal in late-stage trial
AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's disease, the company said on Thursday.Patients showed a statistically significant improvement when two fixed doses of the drug,
AbbVie's dopamine-focused Parkinson's treatment reduces disease burden in phase 3 trial
AbbVie plans to share results from another phase 3 trial of tavapadon later this year, the pharma said in the release. That trial is testing the drug as a flexible-dose monotherapy.
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
AbbVie reports positive Phase 3 results for tavapadon, a once-daily treatment for early-stage Parkinson's disease. The drug showed significant improvements in patient symptoms, meeting primary and secondary endpoints.
AbbVie: Tavapadon Meets Primary, Secondary Endpoints In Phase 3 Trial In Early Parkinson's Disease
Drugmaker AbbVie (ABBV) announced Thursday positive topline results from its pivotal Phase 3 TEMPO-1 trial for tavapadon as a
AbbVie Parkinson’s drug helps improve symptoms in late-stage study
AbbVie reported Thursday that its experimental Parkinson’s drug that it got from Cerevel Therapeutics helped alleviate symptoms and improve quality of life in a late-stage study. In the Phase 3 trial,
AbbVie Parkinson's disease therapy hits main goal in late-stage trial
AbbVie (NYSE:ABBV) announced Thursday its experimental therapy Tavapadon for Parkinson's disease reached the primary endpoint in a Phase 3 trial, indicating a statistically significant improvement in disease severity as a single agent.
Daily Independent4h
Woman's antidrug treatment for Parkinson's isn't sustainable
First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...
What Is Parkinson’s Disease? What to Know About Brett Favre’s Diagnosis
The retired N.F.L. quarterback Brett Favre told a congressional committee on Tuesday that he had been diagnosed with ...
Medical Moment: New blood test detects Parkinson’s disease
A tremor that won’t stop, slow movements, rigid muscles they’re the classic signs of Parkinson’s disease that alert doctors ...
Unlocking the energy crisis in Parkinson's: New findings on metabolic disruptions
Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its ...
Annovis Bio: Progress With Buntanetap In Parkinson's Disease, But Cash Runway Concerns Loom
Annovis Bio saw promising results for Buntanetap in treating Alzheimer's and Parkinson's, but short cash runway prompts a ...
ConsumerAffairs12h
Study: People self-treating Parkinson's with coffee without seeking medical advice
All of a sudden, the health benefits of coffee has become a hot topic. Now comes a new study that suggests people are ...
Right-side deep brain stimulation may preserve verbal fluency in Parkinson's patients
Deep brain stimulation is an effective treatment for motor symptoms in patients with movement disorders such as Parkinson's ...
What Is Parkinson’s Disease?
Brett Favre announced his diagnosis on Tuesday. Here’s what we know about the disease and its relationship to head injuries.
Brett Favre Says He Has Parkinson’s, Likely From Countless Concussions
Brett Favre, former star quarterback for the Green Bay Packers, disclosed Tuesday that he was recently diagnosed with ...
Parkinson's Diagnosis Came After Favre Began Struggling With His Right Arm, He Tells TMZ Sports
Brett Favre told TMZ Sports that he was diagnosed with Parkinson’s disease in January after he began having trouble using his right arm and was unable to hold a screwdriver steady ...